Reserved area: Log in


105 results for tag « science »

REGENIXIR®, regeneration and cellular interconnectivity

 Monday 10 January 2022

To cope with an aggression, several systems (cutaneous, immune, vascular) cooperate to revitalize the cellular interactions indispensable for cutaneous regeneration. Even though this dynamic process exists for the entire lifetime, it is altered with age, as shown by the original modeling studies developed by SILAB. REGENIXIR® is an anti-aging active ingredient from biotechnological origin, that reinforces the interconnectivity of the cutaneous, vascular and immune systems, that is weakened in the course of aging, to provide a regenerating effect.

Read more

Cranberry biopeptides: a sustainable approach

 Monday 08 November 2021

It is known for its tangy taste and its healthful polyphenols. It is again discovered in a cosmetic active ingredient that concentrates the biopeptides of its press cake. SILAB highlights the cranberry and its co-product in PEPTILIUM®, a natural active ingredient obtained with a sustainable and responsible approach.

Read more

A natural anti-acne care for adults

 Thursday 30 September 2021

Acne is a chronic multifactor pathology characterized by the appearance of non-inflammatory and inflammatory lesions. It is one of the most frequent reasons for appointments with dermatologists (20% of consultations).

Read more

PEPTILIUM®, the excellence of natural biopeptides for an anti-aging effect

 Tuesday 31 August 2021

Peptides are valuable allies in anti-aging cosmetics. Whether of natural or synthetic origin, they are recognized for their efficacy. As an expert in naturality, SILAB proposes PEPTILIUM®, an anti- aging active ingredient rich in natural biopeptides purified to 95%, combining high efficacy, transversality and safety.

Read more

SILAB - Jean PAUFIQUE Corporate Foundation: the 2021 prize-winner

 Thursday 22 July 2021

The SILAB - Jean PAUFIQUE Corporate Foundation has named the 14th prize-winner in its history, since its creation in 2007.

Read more

1 2 3 ...